A New Drug Discovery Platform: Application to DNA Polymerase Eta and Apurinic/Apyrimidinic Endonuclease 1

A New Drug Discovery Platform: Application to DNA Polymerase Eta and Apurinic/Apyrimidinic Endonuclease 1

The ability to quickly discover reliable hits from screening and rapidly convert them into lead compounds, which can be verified in functional assays, is central to drug discovery. The expedited validation of novel targets and the identification of modulators to advance to preclinical studies can si...

Full description

Bibliographic Details
Main Authors:	Debanu Das, Matthew A. J. Duncton, Taxiarchis M. Georgiadis, Patricia Pellicena, Jennifer Clark, Robert W. Sobol, Millie M. Georgiadis, John King-Underwood, David V. Jobes, Caleb Chang, Yang Gao, Ashley M. Deacon, David M. Wilson
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	International Journal of Molecular Sciences
Subjects:	fragment-based drug discovery structure-based drug discovery X-ray crystallography cancer therapeutics DNA damage response polymerases
Online Access:	https://www.mdpi.com/1422-0067/24/23/16637

Similar Items

The role of ubiquitylation in regulating apurinic/apyrimidinic endonuclease 1
by: Meisenberg, C
Published: (2012)

Role of phase partitioning in coordinating DNA damage response: focus on the Apurinic Apyrimidinic Endonuclease 1 interactome
by: Tosolini Damiano, et al.
Published: (2020-12-01)

Identification and characterization of inhibitors of human apurinic/apyrimidinic endonuclease APE1.
by: Anton Simeonov, et al.
Published: (2009-06-01)

Too weak for biophysics: Prioritising and progressing fragment hits from X-ray crystallographic screening.
by: Dubianok, Y
Published: (2021)

Apurinic/Apyrimidinic Endonuclease 1 and Tyrosyl-DNA Phosphodiesterase 1 Prevent Suicidal Covalent DNA-Protein Crosslink at Apurinic/Apyrimidinic Site
by: Natalia A. Lebedeva, et al.
Published: (2021-01-01)

Characterization of biochemical properties of an apurinic/apyrimidinic endonuclease from Helicobacter pylori.
by: Aigerim Turgimbayeva, et al.
Published: (2018-01-01)

Targeting the ubiquitin system by fragment-based drug discovery
by: Cassandra Kennedy, et al.
Published: (2022-09-01)

The Role of Active-Site Plasticity in Damaged-Nucleotide Recognition by Human Apurinic/Apyrimidinic Endonuclease APE1
by: Anatoly A. Bulygin, et al.
Published: (2020-08-01)

Large-scale comparison between the diffraction-component precision indexes favors Cruickshank’s Rfree function
by: Avram Sorin, et al.
Published: (2022-01-01)

Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases
by: Theo Battista, et al.
Published: (2020-04-01)

Altered endoribonuclease activity of apurinic/apyrimidinic endonuclease 1 variants identified in the human population.
by: Wan Cheol Kim, et al.
Published: (2014-01-01)

Application of Fragment-Based Drug Discovery to Versatile Targets
by: Qingxin Li
Published: (2020-08-01)

Total sequence decomposition distinguishes functional modules, "molegos" in apurinic/apyrimidinic endonucleases
by: Braun Werner, et al.
Published: (2002-11-01)

Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges
by: Namdev S. Togre, et al.
Published: (2022-09-01)

SemaTyP: a knowledge graph based literature mining method for drug discovery
by: Shengtian Sang, et al.
Published: (2018-05-01)

Endonuclease IV Is the major apurinic/apyrimidinic endonuclease in Mycobacterium tuberculosis and is important for protection against oxidative damage.
by: Rupangi Verma Puri, et al.
Published: (2013-01-01)

Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence
by: José T. Moreira-Filho, et al.
Published: (2021-05-01)

Common Kinetic Mechanism of Abasic Site Recognition by Structurally Different Apurinic/Apyrimidinic Endonucleases
by: Alexandra A. Kuznetsova, et al.
Published: (2021-08-01)

JNK mediates cell death by promoting the ubiquitination of the apurinic/apyrimidinic endonuclease APE1
by: Bahareh Tabanifar, et al.
Published: (2023-09-01)

JNK mediates cell death by promoting the ubiquitination of the apurinic/apyrimidinic endonuclease APE1
by: Tabanifar, Bahareh, et al.
Published: (2023)

Cloning and characterization of a wheat homologue of apurinic/apyrimidinic endonuclease Ape1L.
by: Botagoz Joldybayeva, et al.
Published: (2014-01-01)

The role of genotype/phenotype at apurinic/apyrimidinic endonuclease Rs1130409 in renal cell carcinoma
by: Cheng-Hsi Liao, et al.
Published: (2020-01-01)

Ketamine: A Neglected Therapy for Alzheimer Disease
by: Neil R. Smalheiser
Published: (2019-07-01)

Hydrophobic Waters in Bromodomains
by: Serena G. Piticchio, et al.
Published: (2019-08-01)

α1-Adrenoceptor agonist methoxamine inhibits base excision repair via inhibition of apurinic/apyrimidinic endonuclease 1 (APE1)
by: Kohutova Aneta, et al.
Published: (2023-06-01)

Deep imputation on large‐scale drug discovery data
by: Benedict W. J. Irwin, et al.
Published: (2021-09-01)

Forces Driving a Magic Bullet to Its Target: Revisiting the Role of Thermodynamics in Drug Design, Development, and Optimization
by: Conceição A. Minetti, et al.
Published: (2022-09-01)

Editorial: Integration of structural biology data in lead drug discovery and optimization
by: Pietro Roversi, et al.
Published: (2023-02-01)

Green Drug Discovery: Novel Fragment Space from the Biomass-Derived Molecule Dihydrolevoglucosenone (Cyrene<sup>TM</sup>)
by: Tom Dekker, et al.
Published: (2023-02-01)

A specific DNA-nanoprobe for tracking the activities of human apurinic/apyrimidinic endonuclease 1 in living cells
by: Zhai, J, et al.
Published: (2017)

Correction: Cloning and Characterization of a Wheat Homologue of Apurinic/Apyrimidinic Endonuclease Ape1L
Published: (2014-01-01)

Prognostic value of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in breast cancer.
by: Joohyun Woo, et al.
Published: (2014-01-01)

Correction: Cloning and Characterization of a Wheat Homologue of Apurinic/Apyrimidinic Endonuclease Ape1L.
Published: (2014-01-01)

Applications and prospects of cryo-EM in drug discovery
by: Kong-Fu Zhu, et al.
Published: (2023-03-01)

New therapeutic strategies for type 2 diabetes : small molecule approaches /
by: Jones, Robert M., et al.
Published: (2012)

Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design
by: Shaherin Basith, et al.
Published: (2018-03-01)

Mitochondrial apurinic/apyrimidinic endonuclease 1 enhances mtDNA repair contributing to cell proliferation and mitochondrial integrity in early stages of hepatocellular carcinoma
by: Veronica Bazzani, et al.
Published: (2020-10-01)

Fragment Screening in the Development of a Novel Anti-Malarial
by: Xiaochen Du, et al.
Published: (2023-11-01)

Decomposition of Small Molecules for Fragment-Based Drug Design
by: Nikita N. Ivanov, et al.
Published: (2023-05-01)

Inner Amino Acid Contacts Are Key Factors of Multistage Structural Rearrangements of DNA and Affect Substrate Specificity of Apurinic/Apyrimidinic Endonuclease APE1
by: Anatoly A. Bulygin, et al.
Published: (2023-07-01)